Although we compared protein expression in breast cancer and lung cancer cells with normal breast and lung cancer cells through online database analysis and experiments, further evidence is needed to determine the mechanisms associated with SLMO2 affecting functional changes in breast cancer cells and even other cancers. Here, PRELID3B is linked to lung carcinoma.